NCT02901548 2022-07-29
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
Clinical Trials
4 trialsNCT00260598 2018-09-13
LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer
University of Pittsburgh
Phase 2 Terminated
NCT03106610 2018-05-24
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00410865 2011-12-07
Wild Type p53 Adenovirus for Oral Premalignancies
M.D. Anderson Cancer Center
Phase 1 Terminated